Use of global assessment measures in dementia drug trials

Kenneth Rockwood

doi:10.1016/0895-4356(94)90039-6

Use of global assessment measures in dementia drug trials

Kenneth Rockwood

Résultat de recherche: Article › examen par les pairs

23 Citations (Scopus)

Résumé

I argue in this paper that the use of a global clinical impression of change as a primary measure in dementia drug trials is appropriate, given that we do not yet understand clearly enough what Alzheimer's disease looks like as it gets better.

Langue d'origine	English
Pages (de-à)	101-103
Nombre de pages	3
Journal	Journal of Clinical Epidemiology
Volume	47
Numéro de publication	1
DOI	https://doi.org/10.1016/0895-4356(94)90039-6
Statut de publication	Published - janv. 1994

Note bibliographique

Funding Information:
Acknowledgements-This work was supported in part by the National Health Research Development Program of Health and Welfare Canada, through a National Health Research Scholar Award to the author.

ASJC Scopus Subject Areas

Epidemiology

Accès au document

10.1016/0895-4356(94)90039-6

Autres fichiers et liens

Citer

@article{fc07394115eb4be0a79c3f9ac4eede67,

title = "Use of global assessment measures in dementia drug trials",

abstract = "I argue in this paper that the use of a global clinical impression of change as a primary measure in dementia drug trials is appropriate, given that we do not yet understand clearly enough what Alzheimer's disease looks like as it gets better.",

author = "Kenneth Rockwood",

note = "Funding Information: Acknowledgements-This work was supported in part by the National Health Research Development Program of Health and Welfare Canada, through a National Health Research Scholar Award to the author.",

year = "1994",

month = jan,

doi = "10.1016/0895-4356(94)90039-6",

language = "English",

volume = "47",

pages = "101--103",

journal = "Journal of Clinical Epidemiology",

issn = "0895-4356",

publisher = "Elsevier USA",

number = "1",

}

TY - JOUR

T1 - Use of global assessment measures in dementia drug trials

AU - Rockwood, Kenneth

N1 - Funding Information: Acknowledgements-This work was supported in part by the National Health Research Development Program of Health and Welfare Canada, through a National Health Research Scholar Award to the author.

PY - 1994/1

Y1 - 1994/1

N2 - I argue in this paper that the use of a global clinical impression of change as a primary measure in dementia drug trials is appropriate, given that we do not yet understand clearly enough what Alzheimer's disease looks like as it gets better.

AB - I argue in this paper that the use of a global clinical impression of change as a primary measure in dementia drug trials is appropriate, given that we do not yet understand clearly enough what Alzheimer's disease looks like as it gets better.

UR - http://www.scopus.com/inward/record.url?scp=0028069599&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028069599&partnerID=8YFLogxK

U2 - 10.1016/0895-4356(94)90039-6

DO - 10.1016/0895-4356(94)90039-6

M3 - Article

C2 - 8283190

AN - SCOPUS:0028069599

SN - 0895-4356

VL - 47

SP - 101

EP - 103

JO - Journal of Clinical Epidemiology

JF - Journal of Clinical Epidemiology

IS - 1

ER -

Use of global assessment measures in dementia drug trials

Résumé

Note bibliographique

ASJC Scopus Subject Areas

Accès au document

Autres fichiers et liens

Empreinte numérique

Citer